Geron (GERN) Cash from Financing Activities (2010 - 2026)

Geron's (GERN) quarterly Cash from Financing Activities came in at $2.4 million in Q1 2026, up 847.27% year-on-year from $256000.0 in Q1 2025, and up 541.53% quarter-over-quarter from $378000.0 in Q4 2025.

Geron (GERN) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Geron has disclosed Cash from Financing Activities across 17 years of filings, most recently posting $2.4 million for Q1 2026.

  • Cash from Financing Activities for Q1 2026 came in at $2.4 million, up 847.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.4 million (down 97.63% YoY), and the FY2025 annual result was $2.3 million, down 99.32% from the prior year.
  • Cash from Financing Activities came in at $2.4 million for Q1 2026 at Geron, up from $378000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $281.0 million in Q1 2023 to a low of $256000.0 in Q1 2025.
  • The 5-year median for Cash from Financing Activities is $11.9 million (2022), against an average of $47.9 million.
  • Across the five-year window, Cash from Financing Activities sank 99.83% in 2025 and surged 847.27% in 2026, its largest moves.
  • Geron's Cash from Financing Activities stood at $11.9 million in 2022, then jumped by 179.12% to $33.3 million in 2023, then soared by 399.29% to $166.2 million in 2024, then tumbled by 99.77% to $378000.0 in 2025, then surged by 541.53% to $2.4 million in 2026.
  • The last three Cash from Financing Activities figures came in at $2.4 million (Q1 2026), $378000.0 (Q4 2025), and $542000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - 7.00 Mn
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn -600,000.00
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - 53,000.00
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn -538.80 Mn
9 Abivax 91.71 Bn 91.71 Bn - 85,464.43
10 Geron 729,618.77 729,618.77 - 2.43 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.43 Mn
Mar 31, 2026 2.43 Mn
Dec 31, 2025 378,000.00
Dec 31, 2025 378,000.00
Sep 30, 2025 542,000.00
Sep 30, 2025 542,000.00
Jun 30, 2025 1.09 Mn
Jun 30, 2025 1.09 Mn
Mar 31, 2025 256,000.00
Mar 31, 2025 256,000.00
Dec 31, 2024 166.16 Mn
Dec 31, 2024 166.16 Mn
Sep 30, 2024 3.58 Mn
Sep 30, 2024 3.58 Mn
Jun 30, 2024 16.83 Mn
Jun 30, 2024 16.83 Mn
Mar 31, 2024 147.80 Mn
Mar 31, 2024 147.80 Mn
Dec 31, 2023 33.28 Mn
Dec 31, 2023 33.28 Mn